openPR Logo
Press release

Cerebrovascular Diseases Treatment Market worth $7.59 billion by 2030, growing at a CAGR of 5.76% - Exclusive Report by 360iResearch

08-07-2024 01:49 PM CET | Health & Medicine

Press release from: 360iResearch

Cerebrovascular Diseases Treatment Market | 360iResearch

Cerebrovascular Diseases Treatment Market | 360iResearch

The "Cerebrovascular Diseases Treatment Market by Treatment Modality (Endovascular Procedures, Medical Management, Surgical Intervention), Products (Devices, Drug Medication), Disease Type, End-user - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/cerebrovascular-diseases-treatment

Cerebrovascular diseases, including stroke, transient ischemic attack (TIA), aneurysms, and vascular malformations, pose significant public health challenges necessitating effective treatment strategies. These treatments encompass pharmacological interventions, surgical methods, minimally invasive procedures, and neurotherapeutics, aiming to restore normal blood flow, prevent stroke recurrences, and reduce brain damage. The necessity for these treatments is driven by the aging population's increased prevalence of cerebrovascular conditions and the substantial economic burden associated with long-term disability and rehabilitation. Pharmacological treatments such as antihypertensives, antiplatelet agents, and anticoagulants, along with surgical and minimally invasive techniques such as thrombectomy and intra-arterial devices, are pivotal applications. Primary end-use centers include hospitals, ambulatory surgical centers, rehabilitation centers, and research institutions. Key growth factors influencing the market comprise technological advancements, increased stroke incidence, governmental initiatives, and pharmaceutical innovations. Emerging opportunities lie in expanding telemedicine for post-stroke care, integrating AI for diagnostics, fostering public-private partnerships, and investing in R&D, particularly in stem cell therapy and advanced neurotechnologies. Notwithstanding, challenges such as high treatment costs, stringent regulatory hurdles, limited healthcare access in underdeveloped regions, and patient compliance issues can impede market growth. Areas of innovation and research include neuroprotective agents, regenerative medicine, portable diagnostic devices, and genomic medicine. The cerebrovascular diseases treatment market is dynamic and evolving, necessitating stakeholder collaboration and investment in innovative research to address existing limitations and capitalize on growth opportunities.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/cerebrovascular-diseases-treatment

Market Segmentation & Coverage:

This research report categorizes the Cerebrovascular Diseases Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment Modality, market is studied across Endovascular Procedures, Medical Management, and Surgical Intervention.

Based on Products, market is studied across Devices and Drug Medication. The Devices is further studied across Carotid Stents, Cerebral Balloon Angioplasty and Stenting Systems, Clot Retrieval Devices, Coil Embolization Devices, Embolic Protection Systems, Flow Diverter Devices, and Intracranial Stents. The Drug Medication is further studied across Anticoagulants, Antihypertensive Drugs, Antiplatelet Drugs, Cholesterol-lowering Drugs, and Thrombolytics.

Based on Disease Type, market is studied across Hemorrhagic Stroke, Ischemic Stroke, and Transient Ischemic Attack (TIA).

Based on End-user, market is studied across Ambulatory Care Centers, Hospitals & Surgical Centers, and Research Laboratories & Academic Institutes.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Company Profiles:

The report delves into recent significant developments in the Cerebrovascular Diseases Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca, AstraZeneca plc, Bayer AG, BIOGEN INC., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Daiichi Sankyo Co. Ltd., GE HealthCare Technologies Inc., Genentech, Inc., Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Medtronic plc, Merck & Co., Inc., Penumbra, Inc., Pfizer Inc., Sangamo Therapeutics, Inc., Sanofi SA, Siemens Healthineers AG, Sihuan Pharmaceutical Holdings Group Ltd., Takeda Pharmaceutical Co. Ltd., and United Therapeutics Corp..

Introducing 360iResearch AI: Revolutionizing Market Intelligence with AI-Powered Insights for the Cerebrovascular Diseases Treatment Market

We proudly unveil Research AI, a cutting-edge AI product designed to transform how businesses interact with the Cerebrovascular Diseases Treatment Market. Research AI stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, Research AI is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Cerebrovascular Diseases Treatment Market. Embrace the future of market analysis with Research AI, where informed decisions lead to remarkable growth.

Ask Question to Research AI @ https://www.360iresearch.com/library/intelligence/cerebrovascular-diseases-treatment

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Cerebrovascular Diseases Treatment Market, by Treatment Modality
7. Cerebrovascular Diseases Treatment Market, by Products
8. Cerebrovascular Diseases Treatment Market, by Disease Type
9. Cerebrovascular Diseases Treatment Market, by End-user
10. Americas Cerebrovascular Diseases Treatment Market
11. Asia-Pacific Cerebrovascular Diseases Treatment Market
12. Europe, Middle East & Africa Cerebrovascular Diseases Treatment Market
13. Competitive Landscape
14. Competitive Portfolio

Read More @ https://www.360iresearch.com/library/intelligence/cerebrovascular-diseases-treatment

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cerebrovascular Diseases Treatment Market worth $7.59 billion by 2030, growing at a CAGR of 5.76% - Exclusive Report by 360iResearch here

News-ID: 3614105 • Views:

More Releases from 360iResearch

Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Global Treatment Demand
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and expected to reach USD 10.06 billion in 2024, at a CAGR 7.63% to reach USD 15.71 billion by 2030.
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 2023 and expected to reach USD 292.84 billion in 2024, at a CAGR 11.08% to reach USD 552.63 billion by 2030.
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 and expected to reach USD 62.23 billion in 2024, at a CAGR 9.99% to reach USD 110.34 billion by 2030.
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital

All 5 Releases


More Releases for Treatment

Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any